| __timestamp | Alpine Immune Sciences, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 10811000 |
| Thursday, January 1, 2015 | 6844000 | 33001000 |
| Friday, January 1, 2016 | 8586000 | 64936000 |
| Sunday, January 1, 2017 | 6079000 | 99909000 |
| Monday, January 1, 2018 | 8362000 | 127724000 |
| Tuesday, January 1, 2019 | 9467000 | 161524000 |
| Wednesday, January 1, 2020 | 10899000 | 182933000 |
| Friday, January 1, 2021 | 14560000 | 219982000 |
| Saturday, January 1, 2022 | 17968000 | 278139000 |
| Sunday, January 1, 2023 | 22222000 | 309799000 |
Data in motion
In the competitive world of biotechnology, managing operational expenses is crucial for sustainable growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Ultragenyx Pharmaceutical Inc. over a decade, from 2014 to 2023.
Alpine Immune Sciences, Inc. has shown a steady increase in SG&A expenses, growing nearly tenfold from 2014 to 2023. In contrast, Ultragenyx Pharmaceutical Inc. has experienced a more dramatic rise, with expenses increasing by approximately 2,800% over the same period. By 2023, Ultragenyx's SG&A expenses were about 14 times higher than Alpine's, highlighting its aggressive expansion strategy.
This data underscores the differing approaches of these companies in managing operational costs, with Ultragenyx investing heavily in growth and Alpine maintaining a more conservative expenditure strategy.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Blueprint Medicines Corporation and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical Inc. and Novavax, Inc.: SG&A Spending Patterns Compared